Patent · US Expired

2-substituted heterocyclic compounds

US6809093B2 · kind B2 · utility

3Cited by

2References

4Claims

0Family size

Assignee

H. Lee Moffitt Cancer and Research Institute, Inc. · US

Inventors

Charles Raymond Degenhardt · Cincinnati, US
David Joseph Eickhoff · Stanton, US

Key dates

Filing date	Dec 19, 2000
Grant date	Oct 26, 2004
Priority date	—
Expiry date	Dec 19, 2020

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds, compositions, and methods for treating multidrug resistance are disclosed. Suitable compounds are 2-substituted heterocyclic compounds. An example compound has the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.